TEPMETKO® (tepotinib) Receives Positive CHMP Opinion for Patients with Advanced NSCLC with METex14 Skipping Alterations
Business Wire India Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced that the Committee for Medicinal Products for Human Use (CHMP)…